B
Bull
Bull · 25%CGC
$1.78
Scenario price
$0.713
-0.022 (-3.06%)At close
Loading chart…
- High
- 0.756
- Open
- 0.752
- VWAP
- 0.72
- Volume
- 2.41M
- Mkt Cap
- 508.24M
- Low
- 0.702
- Amount
- 1.74M
- EV/EBITDA, TTM
- -6.00
Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.
AI analysis of Canopy Growth Corp (CGC)
SellCanopy Growth Corp is not a good buy right now due to its current price of 0.713, a very low RSI of 17.94 indicating oversold conditions, and a troubling forward P/E of 20.37, which suggests high expectations despite ongoing losses.
Valuation Metrics
The current forward P/E ratio for Canopy Growth Corp (CGC) is 20.37, compared to its 5-year average forward P/E of -1.24.
Alphio AI Price Scenarios for CGC
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
9.510-15FoolCannabis Market Competition: Choosing Between Canopy and Tilray
8.510-13NewsfilterCanopy Growth Secures EU GMP Certification to Enhance European Strategy
6.510-10FoolCannabis Industry Investment Analysis: Comparing Canopy and Tilray
9.510-06FoolCanopy Growth Faces Long-Term Profitability Challenges
9.509-30FoolCanopy Growth Reports Positive EBITDA Outlook
CGC FAQ — answered by Alphio AI
Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).
Canopy Growth Corp is not a good buy right now due to its current price of 0.713, a very low RSI of 17.94 indicating oversold conditions, and a troubling forward P/E of 20.37, which suggests high expectations despite ongoing losses.
Community
More ↗
As mid-term elections approach and marijuana legalization comes up for debate again, $CGC is a chart worth watching. A large triangle pattern is close to a breakout. If it can reclaim its 50 DMA, there could be upside ahead 📈🌿 $1+ looks fairly likely again in the near future.
Show more
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.